Loading clinical trials...
Loading clinical trials...
Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States
Conditions
Interventions
Remdesivir
Locations
10
United States
David Geffen School of Medicine at UCLA (Site #: 5112)
Los Angeles, California, United States
Childrens Hospital (U. Colorado, Denver) NICHD CRS (Site #: 5052)
Denver, Colorado, United States
Pediatric Perinatal HIV Clinical Trials Unit (Site #: 5127)
Miami, Florida, United States
Emory University School of Medicine (Site #: 5030)
Atlanta, Georgia, United States
Rush University Cook County Hospital NICHD CRS (Site #: 5083)
Chicago, Illinois, United States
Lurie Children's Hospital of Chicago (LCH) CRS (Site #: 4001)
Chicago, Illinois, United States
Start Date
March 31, 2021
Primary Completion Date
April 13, 2022
Completion Date
April 13, 2022
Last Updated
June 9, 2023
NCT04565665
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions